We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BLACR market cap is 1.16M. The company's latest EPS is USD 0.0446 and P/E is 242.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -278k | -280k | -411k | -862k | -451k |
| Net Income | 110k | 302k | 78k | -86k | -60k |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -35k | -1.83M |
| Net Income | -35k | 404k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Assets | 71.06M | 71.49M | 72.14M | 36.63M | 37.27M |
| Total Liabilities | 2.47M | 2.61M | 3.18M | 4.11M | 4.82M |
| Total Equity | -1.83M | -2.1M | -2.46M | -3.91M | -4.31M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 1.23M | 36.63M |
| Total Liabilities | 1.26M | 4.11M |
| Total Equity | -37k | -3.91M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Operating | -49k | -396k | -539k | -819k | -42k |
| Investing | -70.21M | -70.21M | -70.21M | -33.83M | -120k |
| Financing | 70.48M | 70.48M | 70.68M | 34.54M | 150k |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Operating | -4k | -819k |
| Investing | N/A | -33.83M |
| Financing | 124k | 34.54M |
| Market Cap | 1.16M |
| Price to Earnings Ratio | 242.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.35k |
| Price to Book Ratio | 3.01 |
| Dividend Yield | - |
| Shares Outstanding | 9.06M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (66.67%) |
| Company Name | Bellevue Life Sciences Acquisition Corporation |
| Address |
8 the green, ste r dover, delaware 19901 |
| Website | https:// |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
